FDA Revision Of "Fee Matrix" For Civil Money Penalties Requested By HIMA
This article was originally published in The Gray Sheet
Executive Summary
FDA should modify the point system outlined in its proposed "Fee Matrix" for calculating civil money penalties (CMPs), the Health Industry Manufacturers Association suggests in Sept. 7 comments to FDA.